221 Natural history of chronic liver disease (CLD) in the dionysos cohort by ten years of follow-up

2004 ◽  
Vol 40 ◽  
pp. 71
Author(s):  
L. Miglioli ◽  
F. Masutti ◽  
L. Croce ◽  
G. Bedogni ◽  
A. Castiglione ◽  
...  
The Lancet ◽  
1972 ◽  
Vol 300 (7792) ◽  
pp. 1388-1393 ◽  
Author(s):  
F.J. Dudley ◽  
P.J. Scheuer ◽  
S. Sherlock

Hepatology ◽  
2003 ◽  
Vol 38 ◽  
pp. 467-467
Author(s):  
M BORTOLAMI ◽  
H WALDNER ◽  
C VENTURI ◽  
R CARDIN ◽  
C CARLOTTO ◽  
...  

The Lancet ◽  
1992 ◽  
Vol 339 (8807) ◽  
pp. 1462-1464 ◽  
Author(s):  
M.T. Hendrickse ◽  
P.J. Thuluvath ◽  
D.R. Triger

Hepatology ◽  
2014 ◽  
Vol 60 (1) ◽  
pp. 158-168 ◽  
Author(s):  
David J. Harman ◽  
Philip V. Kaye ◽  
Rebecca Harris ◽  
Ayako Suzuki ◽  
Anastasios Gazis ◽  
...  

2018 ◽  
Author(s):  
Esperance A K Schaefer

The natural history of chronic liver disease is that of a slowly progressive course, in most cases evolving over the course of years to decades. The rate of progression varies by disease state and comorbid conditions, but fibrosis advances on average by one stage every 7 to 10 years. While the development of fibrosis is reversible when the underlying etiology is successfully treated, a large number of patients present to medical attention once advanced fibrosis has already developed. The ultimate clinical and pathological manifestation of chronic liver disease is cirrhosis. Cirrhosis has long been clinically divided into “compensated” and “decompensated” disease, with an estimated 12-year survival in compensated disease and 2-year survival in decompensated disease. Additional clinical stratifications have been proposed, including a five-stage model progressing from cirrhosis without portal hypertension (hepatic venous pressure gradient below 10 mm Hg) to cirrhosis with portal hypertension, and then cirrhosis complicated by bleeding or other decompensating events. These clinical stages correspond to a step-wise increase in mortality and, with the presence of more than one decompensating event, the five-year mortality approaches 90%. The major complications of cirrhosis include varices with or without hemorrhage, ascites, hepatic encephalopathy, immune dysfunction, renal impairment, and hepatocellular carcinoma. Liver transplantation has provided an avenue to alter the course and outcomes in chronic liver disease, with graft survival rates that reach 80% at 5 years.  This review contains 4 figures, 6 tables and 51 references Key Words: natural history, cirrhosis, mortality, hepatocellular carcinoma, acute-on-chronic liver failure


PLoS ONE ◽  
2021 ◽  
Vol 16 (5) ◽  
pp. e0252218
Author(s):  
Sónia Bernardo ◽  
Ricardo Crespo ◽  
Sofia Saraiva ◽  
Rui Barata ◽  
Sara Gonçalves ◽  
...  

Background Most long-term heavy drinkers do not have clinically evident chronic liver disease (CLD). However, at any time-point, their risk of developing CLD remains unknown. We aimed to evaluate the long-term outcomes of a group of heavy drinkers, without evidence of CLD at baseline. Methods A cohort of 123 long-term heavy drinkers without CLD were prospectively recruited in 2002 and retrospectively followed until 2018. Results At baseline (2002), median alcohol consumption was 271±203g/day during 21.5±20 years, 65% being abstinent during the previous 1.75±5 months. Patients were followed for 14±3 years. During follow-up, 53% reported any alcohol intake. Alcohol consumption during follow-up associated weakly with either 1- or 6-months previous abstinence at baseline. Until 2018, progression to CLD occurred in 6%, associating with years of alcohol intake during follow-up (OR 1.15 [1.01–1.31]) and baseline alkaline-phosphatase (OR 1.05 [1.01–1.10]). During follow-up, being abstinent for at least 1 year positively associated with CLD-free survival. 27% died (55% of cancer–mostly oropharyngeal cancer, 27% of cardiovascular disease, and 9% of liver disease), with a mean age of 71 years [69–74] (10 years less than the expected in the Portuguese population). Achieving abstinence for at least 1 year positively associated with overall survival, while smoking, and hepatic steatosis at baseline associated negatively. Conclusion Long-term heavy drinkers seemed to have a decreased life expectancy compared with the overall Portuguese population. Cancer was the main cause of death. Our results suggest that progression to CLD depends mostly on continued alcohol intake. Alcohol abstinence, even if temporary, seems to decrease the risks of CLD and mortality.


Sign in / Sign up

Export Citation Format

Share Document